Delaet Ingrid sold NBIX
April 1, 2024 · Form 4 insider transaction
Delaet Ingrid sold 272 shares of Neurocrine Biosciences, Inc. at $137.30 per share, a transaction worth $37.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
272
Price
$137.30
Total value
$37.3K
InsiderDelaet Ingrid
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2024
Filing dateApril 3, 2024
Shares owned after7,507
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.